Insider · CIK 0001769668
Michael Aaron Kelly
Files at BOOM (DMC Global Inc.), NEO (NEOGENOMICS INC), FOLD (AMICUS THERAPEUTICS, INC.), PRME (Prime Medicine, Inc.). First filing May 28, 2025, latest May 28, 2025.
In brief
Michael Aaron Kelly files SEC Form 4 as director at NEO (NEOGENOMICS INC), and also at BOOM (DMC Global Inc.), FOLD (AMICUS THERAPEUTICS, INC.), PRME (Prime Medicine, Inc.). Since May 28, 2025, Michael Aaron Kelly has reported 1 open-market buy worth $38k and 0 open-market sells worth $0, the latest filed on May 28, 2025.
A track record needs three past buys with six months of prices behind them; Michael Aaron Kelly has 0, so none is measured yet.
The newest scored trade: bought $38k of NEO on May 27, 2025, filed May 28, 2025, scored 37 (weak).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
NEO: NEOGENOMICS INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 37Weak | NEObuy NEOGENOMICS INC | $38k 5,000 shares | - | +17% from low-60% from high |
Transactions
Every row this insider has filed, 30 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 5, 2026 | PRME Prime Medicine, Inc. | AGrant or award Stock Option (right to buy)derivative | +75,000 | $0.00 | $0 | 75,000 | Jun 8, 2026 |
| Jun 1, 2026 | NEO NEOGENOMICS INC | MOption exercise Common Stock | +23,077 | $0.00 | $0 | 67,086 | Jun 3, 2026 |
| Jun 1, 2026 | NEO NEOGENOMICS INC | MOption exercise Restricted Stock Unitderivative | -23,077 | $0.00 | $0 | 0 | Jun 3, 2026 |
| Jun 1, 2026 | NEO NEOGENOMICS INC | AGrant or award Stock Option (Right to Buy)derivative | +11,069 | $0.00 | $0 | 11,069 | Jun 3, 2026 |
| Jun 1, 2026 | NEO NEOGENOMICS INC | AGrant or award Restricted Stock Unitderivative | +15,970 | $0.00 | $0 | 15,970 | Jun 3, 2026 |
| May 13, 2026 | BOOM DMC Global Inc. | AGrant or award Common Stock | +16,937 | $0.00 | $0 | 65,590 | May 14, 2026 |
| Apr 27, 2026 | FOLD AMICUS THERAPEUTICS, INC. | DDisposition to issuer Common Stock | -72,468 | $14.50 | $1.1M | 0 | Apr 27, 2026 |
| Apr 27, 2026 | FOLD AMICUS THERAPEUTICS, INC. | DDisposition to issuer Stock Options (right to buy)derivative | -36,111 | - | - | 0 | Apr 27, 2026 |
| Apr 27, 2026 | FOLD AMICUS THERAPEUTICS, INC. | DDisposition to issuer Stock Options (right to buy)derivative | -45,423 | - | - | 0 | Apr 27, 2026 |
| Apr 27, 2026 | FOLD AMICUS THERAPEUTICS, INC. | DDisposition to issuer Stock Options (right to buy)derivative | -30,474 | - | - | 0 | Apr 27, 2026 |
| Apr 27, 2026 | FOLD AMICUS THERAPEUTICS, INC. | DDisposition to issuer Stock Options (right to buy)derivative | -42,467 | - | - | 0 | Apr 27, 2026 |
| Apr 27, 2026 | FOLD AMICUS THERAPEUTICS, INC. | DDisposition to issuer Stock Options (right to buy)derivative | -74,872 | - | - | 0 | Apr 27, 2026 |
| Aug 1, 2025 | PRME Prime Medicine, Inc. | DDisposition to issuer Stock Option (right to buy)derivative | -13,510 | - | - | 0 | Aug 5, 2025 |
| Aug 1, 2025 | PRME Prime Medicine, Inc. | AGrant or award Stock Option (right to buy)derivative | +13,510 | - | - | 13,510 | Aug 5, 2025 |
| Aug 1, 2025 | PRME Prime Medicine, Inc. | DDisposition to issuer Stock Option (right to buy)derivative | -9,006 | - | - | 0 | Aug 5, 2025 |
| Aug 1, 2025 | PRME Prime Medicine, Inc. | AGrant or award Stock Option (right to buy)derivative | +9,006 | - | - | 9,006 | Aug 5, 2025 |
| Aug 1, 2025 | PRME Prime Medicine, Inc. | DDisposition to issuer Stock Option (right to buy)derivative | -39,062 | - | - | 0 | Aug 5, 2025 |
| Aug 1, 2025 | PRME Prime Medicine, Inc. | AGrant or award Stock Option (right to buy)derivative | +39,062 | - | - | 39,062 | Aug 5, 2025 |
| Aug 1, 2025 | PRME Prime Medicine, Inc. | DDisposition to issuer Stock Option (right to buy)derivative | -45,000 | - | - | 0 | Aug 5, 2025 |
| Aug 1, 2025 | PRME Prime Medicine, Inc. | AGrant or award Stock Option (right to buy)derivative | +45,000 | - | - | 45,000 | Aug 5, 2025 |
| Jun 5, 2025 | FOLD AMICUS THERAPEUTICS, INC. | AGrant or award Common Stock | +20,414 | $0.00 | $0 | 72,468 | Jun 6, 2025 |
| Jun 5, 2025 | FOLD AMICUS THERAPEUTICS, INC. | AGrant or award Stock Options (right to buy)derivative | +74,872 | $0.00 | $0 | 74,872 | Jun 6, 2025 |
| Jun 4, 2025 | PRME Prime Medicine, Inc. | AGrant or award Stock Option (right to buy)derivative | +55,000 | $0.00 | $0 | 55,000 | Jun 5, 2025 |
| Jun 1, 2025 | NEO NEOGENOMICS INC | MOption exercise Common Stock | +12,254 | $0.00 | $0 | 44,009 | Jun 3, 2025 |
| Jun 1, 2025 | NEO NEOGENOMICS INC | MOption exercise Restricted Stock Unitderivative | -12,254 | $0.00 | $0 | 0 | Jun 3, 2025 |
| Jun 1, 2025 | NEO NEOGENOMICS INC | AGrant or award Stock Option (Right to Buy)derivative | +16,107 | $0.00 | $0 | 16,107 | Jun 3, 2025 |
| Jun 1, 2025 | NEO NEOGENOMICS INC | AGrant or award Restricted Stock Unitderivative | +23,077 | $0.00 | $0 | 23,077 | Jun 3, 2025 |
| May 27, 2025 | NEO NEOGENOMICS INC | POpen-market purchase Common Stockindirect: M Kelly & B Kelly TTEE Michael and Bonnie Kelly Revocable Trust DTD 05/02/2016 | +5,000 | $7.60 | $38k | 5,000 | May 28, 2025 |
| May 14, 2025 | BOOM DMC Global Inc. | AGrant or award Common Stock | +17,580 | $0.00 | $0 | 48,653 | May 15, 2025 |
| Feb 26, 2025 | BOOM DMC Global Inc. | AGrant or award Common Stock | +5,518 | $0.00 | $0 | 31,073 | Feb 27, 2025 |
Questions about Michael Aaron Kelly
Answered from the filings on this page, as of the latest one.
Is Michael Aaron Kelly buying or selling?
Not in the last 12 months. Michael Aaron Kelly's latest open-market trade on SEC Form 4 was bought $38k of NEO on May 27, 2025.
How did Michael Aaron Kelly's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Michael Aaron Kelly has 0.
Where does Michael Aaron Kelly file Form 4?
Michael Aaron Kelly has filed Form 4 at NEO (NEOGENOMICS INC); BOOM (DMC Global Inc.); FOLD (AMICUS THERAPEUTICS, INC.); PRME (Prime Medicine, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.